metformin vs glp-1 Synergistic effects of with liraglutide against endothelial dysfunction through receptor and PKA signalling pathway GLP-1s lower death risk in

J Headache Pain 26 , 202 (2025)

Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025

Pharmacological inhibition of GIPR with anti-GIPR antibodies prevented BW gain in DIO mice and obese cynomolgus monkeys 33

Furthermore, some were these drugs were associated with potential undesirable effects, such as the risk of heart failure or fractures (complications that are especially prevalent in patients with CKD), this is the case of thiazolidinediones, and the use of sulfonylureas and insulin are associated with weight gain or the risk of hypoglycemia

7: 38 [DOI] [PubMed] [Google Scholar] 116.Yip RG, Boylan MO, Kieffer TJ, et al

What is the Wegovy vision loss lawsuit about